Polymorphisms in genes regulating androgen activity among prostate cancer low-risk Inuit men and high-risk Scandinavians

International Journal of Andrology

Volumn 31, Issue 1, 2008, Pages 25-30

  Giwercman, Charlotte ^b   Giwercman, Aleksander ^b   Pedersen, Henning Sloth ^c   Toft, Gunnar ^d   Lundin, Kristina ^b   Bonde, Jens Peter ^d   Giwercman, Yvonne Lundberg ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Centre for Arctic Environmental Medicine   (Greenland)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Androgen receptor; Inuit; Polymorphism; Prostate cancer; SRD5A2

Indexed keywords

ANDROGEN RECEPTOR; STEROID 5ALPHA REDUCTASE 2;

ADULT; ANDROGEN METABOLISM; ARTICLE; CANCER INCIDENCE; GENE CONTROL; GENE FREQUENCY; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GREENLAND; HIGH RISK POPULATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; SCANDINAVIA; SWEDEN; WILD TYPE;

EID: 38049041605     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2007.00750.x     Document Type: Article

References (27)

1. Chamberlain, N. L., Driver, E. D. Miesfeld, R. L. (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22, 3181 3186.
2. Correa-Cerro, L., Wöhr, G., Häussler, J., Berthon, P., Drelon, E., Mangin, P. et al. (1999) (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. European Journal of Human Genetics 7, 357 362.
3. Coughlin, S. S. Hall, I. J. (2002) A review of genetic polymorphisms and prostate cancer risk. Annals of Epidemiology 12, 182 196.
4. Crawford, E. D. (2003) Epidemiology of prostate cancer. Urology 62, 3 12.
5. Dewailly, E., Mulvad, G., Sloth, P. H., Hansen, J. C., Behrendt, N. Hart Hansen, J. P. (2003) Inuit are protected against prostate cancer. Cancer Epidemiology, Biomarkers and Prevention 12, 926 927.
6. Ding, D., Xu, L., Menon, M., Reddy, G. P. Barrack, E. R. (2004) Effect of a short CAG (glutamine) repeat on human androgen receptor function. The Prostate 58, 23 32.
7. Ding, D., Xu, L., Menon, M., Prem Veer Reddy, G. Barrack, E. R. (2005) Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. The Prostate 62, 133 139.
8. Edwards, S. M., Badzioch, M. D., Minter, R., Hamoudi, R., Collins, N., Ardern-Jones, A., et al. (1999) Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. International Journal of Cancer 84, 458 465.
9. Friborg, J., Koch, A., Wohlfarht, J., Storm, H. H. Melbye, M. (2003) Cancer in Greenlandic Inuit 1973-1997: a cohort study. International Journal of Cancer 107, 1017 1022.
10. Gao, T., Marcelli, M. McPhaul, M. J. (1996) Transcriptional activation and transient expression of the human androgen receptor. Journal of Steroid Biochemistry and Molecular Biology 59, 9 20.
11. Giwercman, A., Richiardi, L., Kaijser, M., Ekbom, A. Akre, O. (2005a) Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: a population based case-control study. International Journal of Cancer 6, 994 997.
12. Giwercman, Y. L., Abrahamsson, P. A., Giwercman, A., Gadaleanu, V. Ahlgren, G. (2005b) The 5 alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population. European Urology 48, 679 685.
13. Hakimi, J. M., Schoenberg, M. P., Rondinelli, R. H., Piantadosi, S. Barrack, E. R. (1997) Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clinical Cancer Research 3, 1599 1608.
14. Hemminki, K. (2001) Science and ethics on familial cancers. Genetic Epidemiology 40, 439 444.
15. Hsing, A. W., Chen, C., Chokkalingam, A. P., Gao, Y. T., Dightman, D. A., Nguyen, H. T. et al. (2001) Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiology, Biomarkers and Prevention 10, 1077 1082.
16. Kolonel, L. N., Altshuler, D. Henderson, B. E. (2004) The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nature Reviews. Cancer 4, 519 527.
17. Larsen, L. A., Armstrong, J. S., Gronskov, K., Hjalgrim, H., Brondum-Nielsen, K., Hasholt, L., Norgaard-Pedersen, B. Vuust, J. (1999) Analysis of FMR1 (CGG)n alleles and FRAXA microsatellite haplotypes in the population of Greenland: implications for the population of the New World from Asia. European Journal of Human Genetics 7, 771 777.
18. Lundin, K. B., Giwercman, A., Richthoff, J., Abrahamsson, P. -A. Giwercman, Y. L. (2003) No association between mutations in the human androgen receptor GGN repeat and inter-sex conditions. Molecular and Human Reproduction 9, 375 379.
19. Makridakis, N. M., di Salle, E. Reichardt, J. K. (2000) Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II. Pharmacogenetics 10, 407 413.
20. Nielsen, N. H. Storm, H. H. (1996) Cancer in Circumpolar Inuit. Background information for the cancer pattern in Greenland. Acta Oncologica 35, 535 537.
21. Nielsen, N. H., Storm, H. H., Gaudette, L. A. Lanier, A. P. (1996) Cancer in Circumpolar Inuit 1969-1988. A summary. Acta Oncologica 35, 621 628.
22. Prener, A., Storm, H. H. Nielsen, N. H. (1996) Cancer of the male genital tract in Circumpolar Inuit. Acta Oncologica 35, 589 593.
23. Quigley, C. A., De Bellis, A., Marschke, K. B., El-Awady, M. K., Wilson, E. M. French, F. S. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 16, 271 321.
24. Richthoff, J., Rylander, L., Hagmar, L., Malm, J. Giwercman, A. (2002) Higher sperm counts in Southern Sweden compared with Denmark. Human Reproduction 17, 2468 2473.
25. Schatzl, G., Madersbacher, S., Gsur, A., Preyer, M., Haidinger, G., Haitel, A., Vutuc, C., Micksche, M. Marberger, M. (2002) Association of polymorphisms within androgen receptor, 5 alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. The Prostate 52, 130 138.
26. Stanford, J. L., Just, J. J., Gibbs, M., Wicklund, K. G., Neal, C. L., Blumenstein, B. A. Ostrander, E. A. (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Research 57, 1194 1198.
27. Terry, P., Lichtenstein, P., Feychting, M., Ahlbom, A. Wolk, A. (2001) Fatty fish consumption and risk of prostate cancer. Lancet 357, 1764 1766.